7,500,000 Units Biotech Group Acquisition Corporation UNDERWRITING AGREEMENTUnderwriting Agreement • June 7th, 2023 • Biotech Group Acquisition Corp • Blank checks • New York
The undersigned, Biotech Group Acquisition Corporation, a newly formed blank check company formed as a Delaware corporation (the “Company”), hereby confirms its agreement with US Tiger Securities, Inc (“US Tiger,” or the “Representative”) and with the other underwriters named on Schedule A hereto for which you are acting as representative (the Representative and the other Underwriters being collectively referred to herein as the “Underwriters” or, individually, an “Underwriter”), as follows:
Biotech Group Acquisition Corporation 2400 Barranca Pkwy, Suite 300 Irvine, CA 92606Underwriting Agreement • June 7th, 2023 • Biotech Group Acquisition Corp • Blank checks
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and between among Biotech Group Acquisition Corporation, a Delaware corporation (the “Company”), and US Tiger Securities, Inc. (“US Tiger”), relating to an underwritten initial public offering (the “Public Offering”), of up to 7,500,000 of the Company’s units (including up to 1,125,000 units that may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), and one redeemable warrant. Each Warrant (each, a “Warrant”) entitles the holder thereof to purchase one share of Class A Common Stock at a price of $11.50 per share, subject to adjustment. The Units shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Company with th
